Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-08
DOI
10.3389/fneur.2021.656294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Tolerability of Calcitonin Gene-Related Peptide Targeted Monoclonal Antibody Medications as Add-on Therapy to OnabotulinumtoxinA in Patients with Chronic Migraine
- (2021) Fred Cohen et al. PAIN MEDICINE
- Dual Therapy With Anti‐CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
- (2020) Lanfranco Pellesi et al. HEADACHE
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- European headache federation consensus on the definition of resistant and refractory migraine
- (2020) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
- (2020) Antonio Russo et al. JOURNAL OF HEADACHE AND PAIN
- OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use
- (2020) James E. Frampton CNS DRUGS
- Current and emerging evidence-based treatment options in chronic migraine: a narrative review
- (2019) Elio Clemente Agostoni et al. JOURNAL OF HEADACHE AND PAIN
- Whatʼs New in the Treatment of Migraine?
- (2019) Kathleen B. Digre JOURNAL OF NEURO-OPHTHALMOLOGY
- Is targeting CGRP the right pathway to prevent migraine?
- (2019) Alessandro Tessitore et al. LANCET
- Botulinum toxin: A review of the mode of action in migraine
- (2018) T. P. Do et al. ACTA NEUROLOGICA SCANDINAVICA
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2018) Messoud Ashina et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
- (2015) Délia Szok et al. Toxins
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- Polytherapy for migraine prophylaxis
- (2012) G. Casucci et al. NEUROLOGICAL SCIENCES
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started